Blood Culture Test Market by Method (Manual, Automated), Product (Consumables, Instrument), Application (Aerobic, Anaerobic, Yeast/ Fungi) & End User (Hospital, Reference Laboratory, Clinical Laboratory, Academic Research Institute) – Forecast to 2019

“The blood culture test market is categorized on the basis of methods, products, applications, end users, and regions. Factors such as increasing demand for rapid diagnostic techniques, high prevalence of infectious diseases, increase in healthcare expenditure and rising aging population are driving the growth of this market. Moreover, increasing blood stream infections (BSI) is another major factor propelling the growth of this market. According to the U.S. CDC (Centres for Disease Control and Prevention), catheter-related blood stream infection (CRBSI) is the most common cause for healthcare-associated blood stream infection. Around 12% to 25% of patients who acquire BSI die every year while some of them have to prolong their hospital stay leading to increase in the overall treatment cost. A treatment of CRBSI can cost up to $56,000, once the cost of pharmacy increases, the cost of catheter and additional diagnostic tests also increases which leads to the increase in the overall healthcare cost.
The relatively untapped Asian region provides an array of growth opportunities for the blood culture test market. A large population base, rapid urbanization, increase in blood stream infection (BSI), rising prevalence of infectious diseases, rising aging population, increasing product availability, and technological advancements are some of the factors responsible for the growth of this market.
To leverage these market opportunities and to reduce the manufacturing and distribution costs, various market players are building manufacturing facilities and strengthening their sales force in these developing economies. However, high cost of automated blood culture systems and lack of adequate reimbursement are hindering the growth of this market.
Apart from the comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on the key players in the blood culture test market and their product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make informed decisions regarding product offerings, geographical focus, and change in strategic approach; R&D investments for innovations in products and technologies; and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of top players in the blood culture test market. The report analyzes the blood culture test market by method, product, application, end user, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the blood culture test market
• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the blood culture test market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for blood culture test products across geographies
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the blood culture test market
”

“TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 20
1.5 LIMITATIONS 20
1.6 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 MARKET SIZE ESTIMATION 22
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.3 KEY INDUSTRY INSIGHTS 28
2.4 ASSUMPTIONS FOR THE STUDY 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 35
4.1 BLOOD CULTURE TESTS MARKET, BY METHOD 35
4.2 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY 35
4.3 BLOOD CULTURE TESTS MARKET, BY APPLICATION 36
4.4 GEOGRAPHIC SNAPSHOT OF THE BLOOD CULTURE TESTS MARKET 36
4.5 BLOOD CULTURE TESTS MARKET, BY END USER 37
5 MARKET OVERVIEW 38
5.1 INTRODUCTION 39
5.2 MARKET SEGMENTATION 39
5.2.1 BY METHOD 39
5.2.2 BY PRODUCT 40
5.2.3 BY TECHNOLOGY 40
5.2.4 BY APPLICATION 41
5.2.5 BY END USER 41
5.2.6 BY REGION 42
5.3 MARKET DYNAMICS 42
5.4 DRIVERS 44
5.4.1 HIGH INCIDENCE OF BLOOD STREAM INFECTIONS 44
5.4.2 INCREASE IN DEMAND FOR RAPID DIAGNOSTIC TECHNIQUES 44
5.4.3 HIGH PREVALENCE OF INFECTIOUS DISEASES 44
5.4.4 RAPID RISE IN AGING POPULATION 44
5.4.5 TECHNOLOGICAL ADVANCEMENTS 45
5.5 RESTRAINTS 46
5.5.1 HIGH COSTS OF AUTOMATED INSTRUMENTS 46
5.5.2 STRINGENT REGULATORY APPROVAL PROCESSES 46
5.6 OPPORTUNITIES 47
5.6.1 EMERGING MARKETS 47
5.6.2 IDENTIFICATION OF ANTIBIOTIC-RESISTANT MICROORGANISMS 47
5.7 CHALLENGES 48
5.7.1 MARKET CANNIBALIZATION 48
5.7.2 SURVIVAL OF SMALL PLAYERS 48
5.8 BURNING ISSUES 49
5.8.1 LABORATORY AUTOMATION FOR INCREASED EFFICIENCY AND ACCURATE DIAGNOSIS 49
6 INDUSTRY INSIGHTS 50
6.1 INTRODUCTION 50
6.2 PORTER’S FIVE FORCES ANALYSIS 50
6.2.1 THREAT OF NEW ENTRANTS 51
6.2.2 THREAT OF SUBSTITUTES 51
6.2.3 INTENSITY OF COMPETITIVE RIVALRY 51
6.2.4 BARGAINING POWER OF BUYERS 51
6.2.5 BARGAINING POWER OF SUPPLIERS 51
6.3 STRATEGIC BENCHMARKING 52
7 BLOOD CULTURE TESTS MARKET, BY PRODUCT 53
7.1 INTRODUCTION 54
7.2 CONSUMABLES 55
7.2.1 BLOOD CULTURE MEDIA 56
7.2.1.1 Aerobic blood culture media 58
7.2.1.2 Anaerobic blood culture media 60
7.2.1.3 Mycobacterial blood culture media 61
7.2.1.4 Fungi/yeast blood culture media 62
7.2.2 ASSAY KITS & REAGENTS 63
7.2.3 OTHER CONSUMABLES 64
7.3 INSTRUMENTS 66
7.3.1 AUTOMATED BLOOD CULTURE SYSTEMS 68
7.3.2 COLONY COUNTERS 70
7.3.3 INCUBATORS 71
7.3.4 MICROSCOPES 72
7.3.5 GRAM STAINERS 73
7.4 SOFTWARE AND SERVICES 74
8 BLOOD CULTURE TESTS MARKET, BY METHOD 76
8.1 INTRODUCTION 77
8.2 CONVENTIONAL/MANUAL BLOOD CULTURE METHODS 78
8.3 AUTOMATED BLOOD CULTURE METHODS 80
9 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY 82
9.1 INTRODUCTION 83
9.2 CULTURE-BASED TECHNOLOGY 84
9.3 MOLECULAR TECHNOLOGIES 85
9.3.1 PCR (POLYMERASE CHAIN REACTION) 87
9.3.2 PNA-FISH (PEPTIDE NUCLEIC ACID- FLUROSCENT IN SITU HYBRIDIZATION) 88
9.3.3 MICROARRAY 89
9.4 PROTEOMICS TECHNOLOGY 91
10 BLOOD CULTURE TESTS MARKET, BY APPLICATION 93
10.1 INTRODUCTION 94
10.2 BACTEREMIA 95
10.3 FUNGEMIA 97
10.4 MYCOBACTERIA 99
11 BLOOD CULTURE TESTS MARKET, BY END USER 101
11.1 INTRODUCTION 102
11.2 HOSPITAL LABORATORIES 104
11.3 CLINICAL DIAGNOSTIC LABORATORIES 105
11.4 REFERENCE LABORATORIES 106
11.5 ACADEMIC RESEARCH INSTITUTES 108
11.6 OTHER END USERS 109
12 BLOOD CULTURE TESTS MARKET, BY REGION 110
12.1 INTRODUCTION 111
12.2 PEST ANALYSIS 111
12.2.1 POLITICAL FACTORS 111
12.2.2 ECONOMIC FACTORS 112
12.2.3 SOCIAL FACTORS 112
12.2.4 TECHNOLOGICAL FACTORS 112
12.3 NORTH AMERICA 115
12.3.1 U.S. 120
12.3.2 CANADA 125
12.4 EUROPE 130
12.5 ASIA 136
12.6 REST OF THE WORLD (ROW) 142
13 COMPETITIVE LANDSCAPE 148
13.1 OVERVIEW 148
13.2 MARKET SHARE ANALYSIS 150
13.2.1 MARKET SHARES OF KEY PLAYERS IN THE BLOOD CULTURE TESTS MARKET (2013) 150
13.3 COMPETITIVE SITUATIONS & TRENDS 151
13.3.1 PRODUCT APPROVALS 152
13.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 155
13.3.3 NEW PRODUCT LAUNCHES 157
13.3.4 ACQUISITIONS 159
13.3.5 EXPANSIONS 160
14 COMPANY PROFILES 161
(Overview, Financials, Products & Services, Strategy, & Developments)*
14.1 INTRODUCTION 161
14.2 BECTON, DICKINSON AND COMPANY 162
14.3 BIOMÉRIEUX SA 165
14.4 THERMO FISHER SCIENTIFIC, INC. 168
14.5 CEPHEID 171
14.6 NANOSPHERE, INC. 175
14.7 ALERE, INC. 178
14.8 BRUKER CORPORATION 180
14.9 BECKMAN COULTER (WHOLLY OWNED SUBSIDIARY OF DANHER CORPORATION) 183
14.10 IRIDICA (A SUBSIDIARY OF ABBOTT LABORATORIES) 186
14.11 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.) 188
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
15 APPENDIX 191
15.1 INSIGHTS FROM INDUSTRY EXPERTS 191
15.2 DISCUSSION GUIDE 192
15.3 OTHER RECENT DEVELOPMENTS 196
15.3.1 BIOMÉRIEUX SA 196
15.3.2 BRUKER CORPORATION 197
15.4 AVAILABLE CUSTOMIZATIONS 198
15.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 198
15.6 RELATED REPORTS 199
“
“LIST OF TABLES

TABLE 1 HIGH INCIDENCE OF BLOOD STREAM INFECTIONS TO FUEL MARKET GROWTH 45
TABLE 2 HIGH COSTS OF AUTOMATED INSTRUMENTS TO RESTRICT MARKET GROWTH 46
TABLE 3 BLOOD CULTURE TESTS MARKET SIZE, BY PRODUCT, 2012-2019($MILLION) 54
TABLE 4 BLOOD CULTURE TESTS MARKET SIZE FOR CONSUMABLES, 
2012-2019($MILLION) 55
TABLE 5 BLOOD CULTURE CONSUMABLES MARKET SIZE, BY REGION, 
2012-2019 ($MILLION) 55
TABLE 6 NORTH AMERICA: BLOOD CULTURE TESTS CONSUMABLES MARKET SIZE, 
BY COUNTRY, 2012-2019 ($MILLION) 56
TABLE 7 BLOOD CULTURE TESTS MARKET SIZE FOR BLOOD CULTURE MEDIA, 
2012-2019($MILLION) 57
TABLE 8 BLOOD CULTURE TESTS MEDIA MARKET SIZE, BY REGION, 2012-2019($MILLION) 58
TABLE 9 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE, BY COUNTRY, 
2012-2019($MILLION) 58
TABLE 10 AEROBIC BLOOD CULTURE MEDIA MARKET SIZE, BY REGION, 
2012-2019 ($MILLION) 59
TABLE 11 NORTH AMERICA: AEROBIC BLOOD CULTURE MEDIA MARKET SIZE, 
BY COUNTRY, 2012-2019($MILLION) 59
TABLE 12 ANAEROBIC BLOOD CULTURE MEDIA MARKET SIZE, BY REGION, 
2012-2019($MILLION) 60
TABLE 13 NORTH AMERICA: ANAEROBIC BLOOD CULUTURE TESTS MARKET SIZE, 
BY COUNTRY, 2012-2019($MILLION) 60
TABLE 14 MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET SIZE, BY REGION, 
2012-2019($MILLION) 61
TABLE 15 NORTH AMERICA: MYCOBACTERIA BLOOD CULTURE TESTS MARKET SIZE, 
BY COUNTRY, 2012-2019($MILLION) 61
TABLE 16 FUNGI/YEAST BLOOD CULTURE MEDIA MARKET SIZE, BY REGION, 
2012-2019($MILLION) 62
TABLE 17 NORTH AMERICA: FUNGI/YEAST BLOOD CULTURE TESTS MARKET SIZE, 
BY COUNTRY 2012-2019($MILLION) 62
TABLE 18 ASSAY KITS & REAGENTS MARKET SIZE, BY REGION, 2012-2019($MILLION) 63
TABLE 19 NORTH AMERICA : ASSAY KITS & REAGENTS MARKET SIZE, BY COUNTRY, 
2012-2019($MILLION) 64
TABLE 20 OTHER CONSUMABLES MARKET SIZE, BY COUNTRY, 2012-2019($MILLION) 65
TABLE 21 NORTH AMERICA: OTHER CONSUMABLE MARKET SIZE, BY COUNTRY, 
2012-2019($MILLION) 65
TABLE 22 BLOOD CULTURE TESTS MARKET SIZE FOR INSTRUMENTS, 2012-2019($MILLION) 67
TABLE 23 INSTRUMENTS MARKET SIZE, BY REGION, 2012-2019($MILLION) 67
TABLE 24 NORTH AMERICA: INSTRUMENTS MARKET SIZE, BY COUNTRY, 
2012-2019($MILLION) 68
TABLE 25 NORTH AMERICA: AUTOMATED BLOOD CULTURE SYSTEMS MARKET SIZE, 
BY REGION 2012-2019($MILLION) 69
TABLE 26 NORTH AMERICA: AUTOMATED BLOOD CULTURE TESTS MARKET SIZE, 
BY COUNTRY, 2012-2019 ($MILLION) 69
TABLE 27 COLONY COUNTERS MARKET SIZE, BY REGION, 2012-2019($MILLION) 70
TABLE 28 NORTH AMERICA: COLONY COUNTERS MARKET SIZE, BY COUNTRY, 
2012-2019($MILLION) 70
TABLE 29 INCUBATORS MARKET SIZE, BY REGION, 2012-2019($MILLION) 71
TABLE 30 NORTH AMERICA: INCUBATOR MARKET SIZE, BY COUNTRY, 2012-2019($MILLION) 71
TABLE 31 NORTH AMERICA: MICROSCOPES MARKET SIZE, BY REGION 
2012-2019($MILLION) 72
TABLE 32 NORTH AMERICA: MICROSCOPE MARKET SIZE, BY COUNTRY, 
2012-2019($MILLION) 72
TABLE 33 GRAM STAINER MARKET SIZE, BY REGION, 2012-2019($MILLION) 73
TABLE 34 NORTH AMERICA: GRAM STAINERS MARKET SIZE, BY REGION, 
2012-2019($MILLION) 73
TABLE 35 SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2012-2014($MILLION) 74
TABLE 36 NORTH AMERICA: SOFTWARE AND SERVICES MARKET SIZE, BY COUNTRY, 
2012-2014 ($MILLION) 75
TABLE 37 BLOOD CULTURE TESTS MARKET SIZE, BY METHOD, 2012-2019 ($MILLION) 77
TABLE 38 CONVENTIONAL/MANUAL BLOOD CULTURE MARKET SIZE, BY REGION, 
2012—2019 ($MILLION) 79
TABLE 39 NORTH AMERICA: CONVENTIONAL/MANUAL BLOOD CULTURE MARKET SIZE, 
BY COUNTRY, 2012-2019 ($MILLION) 80
TABLE 40 AUTOMATED BLOOD CULTURE MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 81
TABLE 41 NORTH AMERICA: AUTOMATED BLOOD CULTURE MARKET SIZE, 
BY COUNTRY, 2012-2019 ($MILLION) 81
TABLE 42 BLOOD CULTURE TESTS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 83
TABLE 43 CULTURE-BASED TECHNOLOGY MARKET SIZE, BY REGION, 2012–2019($MILLION) 84
TABLE 44 NORTH AMERICA: CULTURE-BASED TECHNOLOGY MARKET SIZE, 
BY COUNTRY, 2012–2019($MILLION) 84
TABLE 45 MOLECULAR TECHNOLOGIES MARKET SIZE, BY TYPE, 2012–2019($MILLION) 86
TABLE 46 MOLECULAR TECHNOLOGIES MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 86
TABLE 47 NORTH AMERICA: MOLECULAR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 86
TABLE 48 PCR TECHNOLOGY MARKET SIZE, BY REGION, 2012–2019($MILLION) 87
TABLE 49 NORTH AMERICA: PCR TECHNOLOGY MARKET SIZE, BY COUNTRY, 
2012–2019($MILLION) 88
TABLE 50 PNA-FISH TECHNOLOGY MARKET SIZE, BY REGION, 2012–2019($MILLION) 88
TABLE 51 PNA-FISH TECHNOLOGY MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 89
TABLE 52 MICROARRAY TECHNOLOGY MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 90
TABLE 53 NORTH AMERICA: MICROARRAY TECHNOLOGY MARKET SIZE, BY COUNTRY, 
2012–2019 ($MILLION) 90
TABLE 54 PROTEOMICS TECHNOLOGY MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 91
TABLE 55 NORTH AMERICA: PROTEOMICS TECHNOLOGY MARKET SIZE, BY REGION, 
2012–2019 ($MILLION) 92
TABLE 56 BLOOD CULTURE TESTS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 94
TABLE 57 BACTEREMIA MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 96
TABLE 58 NORTH AMERICA: BACTEREMIA MARKET SIZE, BY COUNTRY, 2012-2019($MILLION) 97
TABLE 59 FUNGEMIA MARKET SIZE, BY REGION, 2012-2019($MILLION) 98
TABLE 60 NORTH AMERICA: FUNGEMIA MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 98
TABLE 61 MYCOBACTERIA MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 99
TABLE 62 NORTH AMERICA: MYCOBACTERIA MARKET SIZE, BY COUNTRY, 
2012-2019($MILLION) 100
TABLE 63 BLOOD CULTURE TESTS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 103
TABLE 64 BLOOD CULTURE TESTS MARKET SIZE FOR HOSPITAL LABORATORIES, BY REGION, 2012-2019 ($MILLION) 104
TABLE 65 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE FOR HOSPITAL LABORATORIES, BY COUNTRY, 2012-2019 ($MILLION) 104
TABLE 66 BLOOD CULTURE TESTS MARKET SIZE FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2012-2019 ($MILLION) 105
TABLE 67 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2012-2019 ($MILLION) 106
TABLE 68 BLOOD CULTURE TESTS MARKET SIZE FOR REFERENCE LABORATORIES, 
BY REGION, 2012-2019 ($MILLION) 107
TABLE 69 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2012-2019 ($MILLION) 107
TABLE 70 BLOOD CULTURE TESTS MARKET SIZE FOR ACADEMIC RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 108
TABLE 71 NORTH AMERICA: ACADEMIC RESEARCH LABORATORIES MARKET SIZE, 
BY COUNTRY, 2012-2014 ($MILLION) 108
TABLE 72 BLOOD CULTURE TESTS MARKET SIZE FOR OTHER END USERS, BY REGION, 
2012-2019 ($MILLION) 109
TABLE 73 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2012-2019 ($MILLION) 109
TABLE 74 BLOOD CULTURE TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 113
TABLE 75 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 
2012–2019 ($MILLION) 114
TABLE 76 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE, BY METHOD, 
2012–2019 ($MILLION) 116
TABLE 77 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE, BY PRODUCT, 
2012–2019 ($MILLION) 116
TABLE 78 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE, BY CONSUMABLE, 2012–2019 ($MILLION) 117
TABLE 79 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE, BY BLOOD CULTURE MEDIA, 2012–2019 ($MILLION) 117
TABLE 80 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE, BY INSTRUMENT, 
2012–2019 ($MILLION) 118
TABLE 81 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE, BY TECHNOLOGY, 
2012–2019 ($MILLION) 118
TABLE 82 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE, BY MOLECULAR TECHNOLOGY, 2012–2019 ($MILLION) 119
TABLE 83 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SIZE, BY APPLICATION, 
2012–2019 ($MILLION) 119
TABLE 84 BLOOD CULTURE TESTS MARKET, BY END USER, 2012–2019 ($MILLION) 120
TABLE 85 U.S.: BLOOD CULTURE TESTS MARKET SIZE, BY METHOD, 2012–2019 ($MILLION) 121
TABLE 86 U.S.: BLOOD CULTURE TESTS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 121
TABLE 87 U.S.: BLOOD CULTURE TESTS MARKET SIZE, BY CONSUMABLE, 
2012–2019 ($MILLION) 121
TABLE 88 U.S.: BLOOD CULTURE TESTS MARKET SIZE, BY BLOOD CULTURE MEDIA, 
2012–2019 ($MILLION) 122
TABLE 89 U.S.: BLOOD CULTURE TESTS MARKET SIZE, BY INSTRUMENT, 
2012–2019 ($MILLION) 122
TABLE 90 U.S.: BLOOD CULTURE TESTS MARKET SIZE, BY TECHNOLOGY, 
2012–2019 ($MILLION) 123
TABLE 91 U.S.: BLOOD CULTURE TESTS MARKET SIZE, BY MOLECULAR TECHNOLOGY, 
2012-2019 ($MILLION) 123
TABLE 92 U.S.: BLOOD CULTURE TESTS MARKET SIZE, BY APPLICATION, 
2012–2019 ($MILLION) 124
TABLE 93 U.S.: BLOOD CULTURE TESTS MARKET SIZE, BY END USER, 
2012–2019 ($MILLION) 124
TABLE 94 CANADA: BLOOD CULTURE TESTS MARKET SIZE, BY METHOD, 
2012–2019 ($MILLION) 125
TABLE 95 CANADA: BLOOD CULTURE TESTS MARKET SIZE, BY PRODUCT, 
2012–2019 ($MILLION) 125
TABLE 96 CANADA: BLOOD CULTURE TESTS MARKET SIZE, BY CONSUMABLE, 
2012–2019 ($MILLION) 126
TABLE 97 CANADA: BLOOD CULTURE TESTS MARKET SIZE, BY BLOOD CULTURE MEDIA, 2012–2019 ($MILLION) 126
TABLE 98 CANADA: BLOOD CULTURE TESTS MARKET SIZE, BY INSTRUMENT, 
2012–2019 ($MILLION) 127
TABLE 99 CANADA: BLOOD CULTURE TESTS MARKET SIZE, BY TECHNOLOGY, 
2012–2019 ($MILLION) 127
TABLE 100 CANADA: BLOOD CULTURE TESTS MARKET SIZE, BY MOLECULAR TECHNOLOGY, 2012–2019 ($MILLION) 128
TABLE 101 CANADA: BLOOD CULTURE TESTS MARKET SIZE, BY APPLICATION, 
2012–2019 ($MILLION) 128
TABLE 102 CANADA: BLOOD CULTURE TESTS MARKET SIZE, BY END USER, 
2012–2019 ($MILLION) 129
TABLE 103 EUROPE: BLOOD CULTURE TESTS MARKET SIZE, BY METHOD, 
2012–2019 ($MILLION) 132
TABLE 104 EUROPE: BLOOD CULTURE TESTS MARKET SIZE, BY PRODUCT, 
2012–2019($MILLION) 132
TABLE 105 EUROPE: BLOOD CULTURE TESTS MARKET SIZE, BY CONSUMABLE, 
2012–2019 ($MILLION) 132
TABLE 106 EUROPE: BLOOD CULTURE TESTS MARKET SIZE, BY BLOOD CULTURE MEDIA, 2012–2019 ($MILLION) 133
TABLE 107 EUROPE: BLOOD CULTURE TESTS MARKET, BY INSTRUMENT, 
2012–2019 ($MILLION) 133
TABLE 108 EUROPE: BLOOD CULTURE TESTS MARKET SIZE, BY TECHNOLOGY, 
2012–2019 ($MILLION) 134
TABLE 109 EUROPE: BLOOD CULTURE TESTS MARKET SIZE, BY MOLECULAR TECHNOLOGY, 2012–2019 ($MILLION) 134
TABLE 110 EUROPE: BLOOD CULTURE TESTS MARKET SIZE, BY APPLICATION, 
2012–2019 ($MILLION) 135
TABLE 111 EUROPE: BLOOD CULTURE TESTS MARKET, BY END USER, 2012–2019 ($MILLION) 135
TABLE 112 ASIA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2012–2019 ($MILLION) 137
TABLE 113 ASIA: BLOOD CULTURE TESTS MARKET SIZE, BY PRODUCT, 2012–2019 (MILLION) 138
TABLE 114 ASIA: BLOOD CULTURE TESTS MARKET, BY CONSUMABLE, 2012–2019($MILLION) 138
TABLE 115 ASIA: BLOOD CULTURE TESTS MARKET SIZE, BY BLOOD CULTURE MEDIA, 
2012–2019 ($MILLION) 139
TABLE 116 ASIA: BLOOD CULTURE TESTS MARKET SIZE, BY INSTRUMENT, 
2012–2019($MILLION) 139
TABLE 117 ASIA: BLOOD CULTURE TESTS MARKET SIZE, BY TECHNOLOGY, 
2012–2019 ($MILLION) 140
TABLE 118 ASIA: BLOOD CULTURE TESTS MARKET SIZE, BY MOLECULAR TECHNOLOGY, 2012–2019 ($MILLION) 140
TABLE 119 ASIA: BLOOD CULTURE TESTS MARKET SIZE, BY APPLICATION, 
2012–2019 ($MILLION) 140
TABLE 120 ASIA: BLOOD CULTURE TESTS MARKET SIZE, BY END USER, 
2012–2019($MILLION) 141
TABLE 121 ROW: BLOOD CULTURE TESTS MARKET SIZE, BY METHOD, 2012–2014($MILLION) 143
TABLE 122 ROW: BLOOD CULTURE TESTS MARKET SIZE, BY PRODUCT, 
2012–2014 ($MILLION) 144
TABLE 123 ROW: BLOOD CULTURE TESTS MARKET SIZE, BY CONSUMABLE, 
2012–2014($MILLION) 144
TABLE 124 ROW: BLOOD CULTURE TESTS MARKET SIZE, BY BLOOD CULTURE MEDIA, 
2012–2019 ($MILLION) 145
TABLE 125 ROW: BLOOD CULTURE TESTS MARKET SIZE, BY INSTRUMENT, 
2012–2019($MILLION) 145
TABLE 126 ROW: BLOOD CULTURE TESTS MARKET SIZE, BY TECHNOLOGY, 
2012–2019 ($MILLION) 146
TABLE 127 ROW: BLOOD CULTURE TESTS MARKET SIZE, BY MOLECULAR TECHNOLOGY, 2012–2019 ($MILLION) 146
TABLE 128 ROW: BLOOD CULTURE TESTS MARKET SIZE, BY APPLICATION, 
2012–2019 ($MILLION) 146
TABLE 129 ROW: BLOOD CULTURE TESTS MARKET SIZE, BY END USER, 
2012–2019 ($MILLION) 147
TABLE 130 PRODUCT APPROVALS 152
TABLE 131 AGREEMENTS, PARTNERSHIPS AND COLLABORATIONS 155
TABLE 132 NEW PRODUCT LAUNCHES 157
TABLE 133 ACQUISITIONS 159
TABLE 134 EXPANSIONS 160
TABLE 135 EXCHANGE RATES (UTILIZED FOR CONVERSION OF EURO TO USD) 166
TABLE 136 EXCHANGE RATES (UTILIZED FOR CONVERSION OF CHF TO USD) 189
“
“LIST OF FIGURES

FIGURE 1 BLOOD CULTURE TESTS MARKET, BY METHOD 18
FIGURE 2 RESEARCH DESIGN 21
FIGURE 3 MARKET SIZE ESTIMATION : BOTTOM-UP APPROACH 23
FIGURE 4 MARKET SIZE ESTIMATION: TOP DOWN APPROACH 23
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 24
FIGURE 6 DATA TRIANGULATION METHODOLOGY 25
FIGURE 7 KEY DATA FROM SECONDARY SOURCES 26
FIGURE 8 KEY DATA FROM PRIMARY SOURCES 27
FIGURE 9 CONSUMABLES TO DOMINATE THE BLOOD CULTURE TESTS MARKET FROM 2014 TO 2019 30
FIGURE 10 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY (2014 VS. 2019): CULTURE-BASED TECHNOLOGY TO WITNESS HIGHEST GROWTH 30
FIGURE 11 BACTEREMIA TO CONTINUE TO DOMINATE THE BLOOD CULTURE TESTS MARKET DURING THE FORECAST PERIOD (2014–2019) 31
FIGURE 12 REFERENCE LABORATORIES TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES 32
FIGURE 13 GEOGRAPHIC ANALYSIS: GLOBAL BLOOD CULTURE TESTS MARKET (2014) 33
FIGURE 14 PRODUCT APPROVALS WERE THE KEY STRATEGY ADOPTED BY MARKET PLAYERS IN 2014 34
FIGURE 15 AUTOMATED BLOOD CULTURE MARKET TO OFFER HIGH GROWTH OPPORTUNITIES 35
FIGURE 16 CULTURE-BASED TECHNOLOGY COMMANDED THE LARGEST SHARE IN 2014 35
FIGURE 17 BACTEREMIA SEGMENT TO GROW AT THE HIGHEST RATE FROM 2014 TO 2019 36
FIGURE 18 ASIA TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 36
FIGURE 19 HOSPITAL LABORATORIES TO OFFER SIGNIFICANT CONTRIBUTION TO THE MARKET GROWTH (2014–2019) 37
FIGURE 20 BLOOD CULTURE TESTS MARKET SEGMENTATION, BY METHOD 39
FIGURE 21 BLOOD CULTURE TESTS MARKET SEGMENTATION, BY PRODUCT 40
FIGURE 22 BLOOD CULTURE TESTS MARKET SEGMENTATION, BY TECHNOLOGY 40
FIGURE 23 BLOOD CULTURE TESTS MARKET SEGMENTATION, BY APPLICATION 41
FIGURE 24 BLOOD CULTURE TESTS SEGMENTATION MARKET, BY END USER 41
FIGURE 25 BLOOD CULTURE TESTS SEGMENTATION MARKET, BY REGION 42
FIGURE 26 HIGH INCIDENCE OF BLOOD STREAM INFECTIONS TO DRIVE THE MARKET GROWTH 43
FIGURE 27 PORTER’S FIVE FORCE ANALYSIS 50
FIGURE 28 MAJOR COMPANIES ADOPTED INORGANIC GROWTH STRATEGIES 52
FIGURE 29 AEROBIC BLOOD CULTURE MEDIA TO DOMINATE BLOOD CULTURE MEDIA MARKET IN 2014 57
FIGURE 30 AUTOMATED BLOOD CULTURE SYSTEMS TO WITNESS HIGH GROWTH IN FORECAST PERIOD 66
FIGURE 31 AUTOMATED BLOOD CULTURE SEGMENT TO OFFER HIGH GROWTH OPPORTUNITIES IN THE FORECAST PERIOD 77
FIGURE 32 CONVENTIONAL/MANUAL BLOOD CULTURE METHOD SEGMENT TO WITNESS HIGH GROWTH IN ASIA 79
FIGURE 33 CULTURE-BASED TECHNOLOGY TO CONTINUE TO DOMINATE THE BLOOD CULTURE TESTS MARKET IN THE FORECAST PERIOD 83
FIGURE 34 PCR TECHNOLOGY TO OFFER HIGH GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD(2014-2019) 85
FIGURE 35 BACTEREMIA TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR THE BLOOD CULTURE TESTS APPLICATIONS MARKET 94
FIGURE 36 ASIA TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR BACTEREMIA APPLICATIONS MARKET(2014-2019) 96
FIGURE 37 BROAD END-USER BASE OF BLOOD CULTURE TESTS 102
FIGURE 38 REFERNCE LABORATORIES: HIGH GROWTH MARKET SEGMENT 103
FIGURE 39 ASIA: AN ATTRACTIVE DESTINATION FOR ALL APPLICATIONS 113
FIGURE 40 NORTH AMERICA HOLDS THE LARGEST SHARE OF THE GLOBAL BLOOD CULTURE TESTS MARKET (2014) 115
FIGURE 41 EUROPEAN BLOOD CULTURE TESTS MARKET SNAPSHOT 131
FIGURE 42 GROWING PRODUCT APPROVALS WILL FUEL THE GROWTH OF THE ASIAN MARKET (2014) 137
FIGURE 43 INCREASING GOVERNMENT FUNDING TO DRIVE THE GROWTH OF THE BLOOD CULTURE TESTS MARKET IN ROW (2014) 143
FIGURE 44 KEY PLAYERS ADOPTED INORGANIC GROWTH STRATEGIES FOR GROWTH 148
FIGURE 45 MARKET EVOLUTION FRAMEWORK 149
FIGURE 46 BATTLE FOR MARKET SHARE: PRODUCT APPROVAL WAS THE KEY GROWTH STRATEGY 151
FIGURE 47 PRODUCT BENCHMARKING FOR TOP 5 PLAYERS 161
FIGURE 48 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY 162
FIGURE 49 COMPANY SNAPSHOT: BIOMÉRIEUX SA 165
FIGURE 50 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC. 168
FIGURE 51 COMPANY SNAPSHOT: CEPHEID 171
FIGURE 52 COMPANY SNAPSHOT: NANOSPHERE, INC. 175
FIGURE 53 COMPANY SNAPSHOT: ALERE INC. 178
FIGURE 54 COMPANY SNAPSHOT: BRUKER CORPORATION 180
FIGURE 55 COMPANY SNAPSHOT: DANAHER CORPORATION 183
FIGURE 56 COMPANY SNAPSHOT: ABBOTT LABORATORIES 186
FIGURE 57 COMPANY SNAPSHOT: ROCHE DIAGNOSTICS 188
“